首页|马来酰亚胺修饰的柠檬苦素纳米粒的制备、表征及其口服药动学研究

马来酰亚胺修饰的柠檬苦素纳米粒的制备、表征及其口服药动学研究

扫码查看
目的 制备马来酰亚胺修饰的柠檬苦素纳米粒(maleimide-modified limonin nanoparticles,Mal-Lim-NPs),对其理化性质进行表征,并研究其口服药动学行为.方法 单因素结合Box-Behnken设计-效应面法(Box-Behnken design-response surface method,BBD-RSM)优化 Mal-Lim-NPs 处方工艺,并制成冻干粉.X 射线粉末衍射法(X-ray powder diffraction,XRPD)分析柠檬苦素在Mal-Lim-NPs冻干粉中的晶型,透射电子显微镜(transmission electron microscope,TEM)观察Mal-Lim-NPs 微观外貌,测定Mal-Lim-NPs冻干粉在pH2.0、5.0、6.8磷酸盐缓冲液(PBS)中的溶解度和释放度.SD大鼠分别ig给予柠檬苦素和Mal-Lim-NPs冻干粉,绘制血药浓度-时间曲线,计算主要药动学参数.结果 Mal-Lim-NPs最佳处方:马来酰亚胺-聚乙二醇-聚乳酸[maleimide-methoxy poly(ethylene glycol)-poly(lactic acid),Mal-PEG-PLA]与柠檬苦素用量比为7.5∶1,水相体积为35 mL,超声时间为13 min.Mal-Lim-NPs的平均包封率、载药量、粒径和ζ电位分别为(81.63±1.30)%、(9.32±0.24)%、(171.56±6.63)nm 和(-16.60±0.92)mV.柠檬苦素在 Mal-Lim-NPs 冻干粉中晶型状态可能发生了改变,冻干粉复溶后Mal-Lim-NPs微观外貌仍近似球形.Mal-Lim-NPs冻干粉在pH2.0、5.0、6.8 PBS中的释药行为均符合Weibull模型.Mal-Lim-NPs达峰时间(tmax)延后至(2.61±0.40)h,末端消除半衰期(t1/2)延长至(6.73±1.54)h,药峰浓度(Cmax)和时间曲线下面积(AUC0~t、AUC0~∞)分别提高至柠檬苦素的4.01倍和5.65、5.89倍.结论 Mal-Lim-NPs改变了柠檬苦素体内药动学行为,显著增加了口服药物吸收,为后续研究奠定基础.
Maleimide-modified limonin nanoparticles:Preparation,characterization and its oral pharmacokinetics study
Objective To prepare maleimide-modified limonin nanoparticles(Mal-Lim-NPs),characterize its physicochemical properties,and study its oral pharmacokinetic behavior.Methods Single factor experiments combined with Box-Behnken response surface design method(BBD-RSM)was used to gain optimal prescriptions of Mal-Lim-NPs,and its lyophilized powder was prepared.Crystal form of limonin in lyophilized powder of Mal-Lim-NPs was analyzed by X-ray powder diffraction(XRPD),and microscopic appearance was observed by transmission electron microscope(TEM).Solubility and drug release rate of Mal-Lim-NPs in pH 2.0,5.0,6.8 phosphate buffers(PBS)were determined.SD rats in each group were administered intragastrically with limonin and Mal-Lim-NPs,respectively,blood drug concentration-time curve was plotted,and main pharmacokinetic parameters was also calculated.Results Optimal prescriptions of Lin-Mal-NP:Mal-PEG-PLA to limonin dosage ratio was 7.5∶1,water phase volume was 35 mL and ultrasonic time was 13 min.Average envelopment efficiency,drug loading,particle size and ζ potential were(81.63±1.30)%,(9.32±0.24)%,(171.56±6.63)nm and(-16.60±0.92)mV,respectively.The crystalline state of limonin maybe changed in Mal-Lim-NPs lyophilized powder.Microcosmic appearance of Mal-Lim-NPs was still nearly spherical after dissolved by water.The release behavior of Mal-Lim-NPs in pH 2.0,5.0,6.8 PBS were in accordance with Weibull model.The tmax of Mal-Lim-NPs delayed to(2.61±0.40)h,t1/2 was increased to(6.73±1.54)h,Cmax and AUC0-t,AUC0-∞ were increased to 4.01-fold and 5.65,5.89-fold,respectively.Conclusion Mal-Lim-NPs changed the pharmacokinetic behavior of limonin in vivo and significantly increased the oral absorption,which laid foundation for the following research.

limoninnanoparticlesmaleimide-modifiedBox-Behnken response surface design methodrelease in vitrooral pharmacokinetics

陈永顺、杨斌

展开 >

商丘医学高等专科学校,河南商丘 476000

广西医科大学,广西南宁 530021

柠檬苦素 纳米粒 马来酰亚胺修饰 Box-Behnken设计-效应面法 体外释药 口服药动学

2025

中草药
天津药物研究院,中国药学会

中草药

北大核心
影响因子:1.632
ISSN:0253-2670
年,卷(期):2025.56(2)